- Moneycontrol /
- Market /
- Pharmaceuticals /
- YEARLY RESULTS
BSE Live
Mar 26, 16:00Prev. Close
291.00
Open Price
304.40
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
| Yearly Results of Mercury Laboratories (in Rs. Cr.) | Mar '19 | Mar '18 | Mar '17 | Mar '16 | Mar '15 | |
| Net Sales/Income from operations | 55.52 | 51.87 | 48.03 | 47.52 | 41.78 | |
| Other Operating Income | -- | -- | -- | -- | -- | |
| Total Income From Operations | 55.52 | 51.87 | 48.03 | 47.52 | 41.78 | |
| EXPENDITURE | ||||||
| Consumption of Raw Materials | 23.33 | 24.95 | 18.16 | 18.81 | 15.44 | |
| Purchase of Traded Goods | 1.26 | -- | 1.74 | 3.23 | 2.48 | |
| Increase/Decrease in Stocks | 1.75 | -1.12 | 0.43 | -1.72 | -0.52 | |
| Power & Fuel | -- | -- | -- | -- | -- | |
| Employees Cost | 7.83 | 7.34 | 6.90 | 7.17 | 6.40 | |
| Depreciation | 1.63 | 1.47 | 1.29 | 1.18 | 1.42 | |
| Excise Duty | -- | -- | -- | -- | -- | |
| Admin. And Selling Expenses | -- | -- | -- | -- | -- | |
| R & D Expenses | -- | -- | -- | -- | -- | |
| Provisions And Contingencies | -- | -- | -- | -- | -- | |
| Exp. Capitalised | -- | -- | -- | -- | -- | |
| Other Expenses | 15.63 | 16.33 | 14.07 | 13.55 | 11.43 | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 4.09 | 2.90 | 5.43 | 5.29 | 5.12 | |
| Other Income | 1.04 | 0.46 | 0.35 | 0.78 | 0.37 | |
| P/L Before Int., Excpt. Items & Tax | 5.14 | 3.36 | 5.79 | 6.07 | 5.49 | |
| Interest | 1.09 | 0.91 | 0.89 | 1.13 | 1.12 | |
| P/L Before Exceptional Items & Tax | 4.05 | 2.46 | 4.89 | 4.94 | 4.38 | |
| Exceptional Items | -- | -- | -- | -- | -- | |
| P/L Before Tax | 4.05 | 2.46 | 4.89 | 4.94 | 4.38 | |
| Tax | 1.21 | 0.44 | 2.19 | 1.01 | 1.54 | |
| P/L After Tax from Ordinary Activities | 2.84 | 2.01 | 2.70 | 3.92 | 2.84 | |
| Prior Year Adjustments | -- | -- | -- | -- | -- | |
| Extra Ordinary Items | -- | -- | -- | -- | -- | |
| Net Profit/(Loss) For the Period | 2.84 | 2.01 | 2.70 | 3.92 | 2.84 | |
| Equity Share Capital | 1.20 | 1.20 | 1.20 | 1.20 | 1.20 | |
| Reserves Excluding Revaluation Reserves | 27.77 | 25.15 | 23.27 | 20.65 | 16.94 | |
| Equity Dividend Rate (%) | 15.00 | 15.00 | 15.00 | 15.00 | 15.00 | |
| EPS Before Extra Ordinary | ||||||
| Basic EPS | 23.64 | 16.78 | 22.53 | 32.69 | 23.68 | |
| Diluted EPS | 23.64 | 16.78 | 22.53 | 32.69 | 23.68 | |
| EPS After Extra Ordinary | ||||||
| Basic EPS. | 23.64 | 16.78 | 22.53 | 32.69 | 23.68 | |
| Diluted EPS. | 23.64 | 16.78 | 22.53 | 32.69 | 23.68 | |
| Public Share Holding | ||||||
| No Of Shares (Crores) | -- | -- | -- | -- | 0.03 | |
| Share Holding (%) | -- | -- | -- | -- | 27.36 | |
| Promoters and Promoter Group Shareholding | ||||||
| a) Pledged/Encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |
| b) Non-encumbered | ||||||
| - Number of shares (Crores). | -- | -- | -- | -- | 0.09 | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group). | -- | -- | -- | -- | 100.00 | |
| - Per. of shares (as a % of the total Share Cap. of the company). | -- | -- | -- | -- | 72.64 |
30.07.2019
Mercury Labs Standalone June 2019 Net Sales at Rs 14.75 crore, up 13.17% Y-o-Y
30.05.2019
Mercury Labs Standalone March 2019 Net Sales at Rs 12.07 crore, down 5.95% Y-o-Y
30.01.2019
Mercury Labs Standalone December 2018 Net Sales at Rs 17.53 crore, up 26.56% Y-o-Y
02.11.2018
Mercury Labs Standalone September 2018 Net Sales at Rs 12.88 crore, down 11.33% Q-o-Q
30.07.2019
Mercury Labs Standalone June 2019 Net Sales at Rs 14.75 crore, up 13.17% Y-o-Y
30.05.2019
Mercury Labs Standalone March 2019 Net Sales at Rs 12.07 crore, down 5.95% Y-o-Y
30.01.2019
Mercury Labs Standalone December 2018 Net Sales at Rs 17.53 crore, up 26.56% Y-o-Y
02.11.2018
Mercury Labs Standalone September 2018 Net Sales at Rs 12.88 crore, down 11.33% Q-o-Q
